21/02/2017 Clare News, Immuno-Oncology
Aquila BioMedical are proud to be silver sponsors of the Next Gen Immuno-Oncology Congress. Our CSO, Prof. Steve Anderton, will be presenting on the first day within the immune checkpoint inhibitors stream. Come along and listen to hear all about how Aquila's suite of IO services can help you accelerate your R&D to expedite clinical progression.
The Next Gen Immuno-Oncology Congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the growth of existing therapeutics and pave way for emerging next generation therapeutics. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced.
To find out more, click here.